scholarly journals Three Cases of Congenital Retinal Macrovessel, One Coexisting with Cilioretinal Artery

2018 ◽  
pp. 52-55 ◽  
Author(s):  
Bayram Gülpamuk ◽  
Pınar Kaya ◽  
Mehmet Yasin Teke
2021 ◽  
pp. 247412642199860
Author(s):  
Jonathan Cin-Bon Tsui ◽  
Gordon Scott Crabtree

Purpose: This work reports a case of combined vascular occlusion in the setting of intravenous immunoglobulin (IVIg) administration. Methods: The authors describe a case of combined central retinal vein and cilioretinal artery that occurred in the setting of IVIg administration. Results: A 52-year-old White man presented with a unilateral subjective scotoma that began during IVIg administered for the treatment of statin-induced necrotizing autoimmune myopathy. Examination and optical coherence tomography imaging revealed a combined nonischemic central retinal vein and cilioretinal artery occlusion. Conclusions: To the authors’ review and knowledge, this is the first reported case of combined central retinal vein and cilioretinal artery occlusion occurring in the setting of IVIg administration. This rare adverse effect is an entity to be considered in patients who are treated with IVIg.


Ophthalmology ◽  
1991 ◽  
Vol 98 (5) ◽  
pp. 594-601 ◽  
Author(s):  
Howard Schatz ◽  
Andrew C.O. Fong ◽  
H. Richard McDonald ◽  
Robert N. Johnson ◽  
Leonard Joffe ◽  
...  

2017 ◽  
Vol 38 (5) ◽  
pp. 428-433 ◽  
Author(s):  
Sarenur Yilmaz ◽  
Aylin Ardagil ◽  
Ibrahim Akalin ◽  
Meltem Guzin Altinel ◽  
Yasar Dag ◽  
...  

2018 ◽  
Vol 25 (4) ◽  
pp. 969-971 ◽  
Author(s):  
Ali Alkan ◽  
Serap Talaz

Introduction Cancer is an important risk factor for venous and arterial thromboembolic events. Treatment with chemotherapy was associated with a 6.5-fold increase in the risk of thromboembolic events. Here, we present a patient with cilioretinal artery emboli during cisplatin-based therapy. Case report A 54-year-old male patient with a diagnosis of metastatic small cell carcinoma was under cisplatin-based regimen. He presented with visual disturbance. Retinal fluorescein angiography showed multiple plaques located in cilioretinal artery and cilioretinal artery occlusion. After excluding other potential etiological factors, patient was diagnosed with cilioretinal artery occlusion associated with cisplatin. Discussion In oncology practice, patients are prone to thromboembolic events due to primary disease, underlying comorbidities and treatment modalities. In addition to numerous toxicities, cisplatin is an important risk factor for thromboembolic events. Clinicians caring patients with a diagnosis of cancer should be aware of this rare complication of cisplatin-based therapies.


Retina ◽  
1983 ◽  
Vol 3 (3) ◽  
pp. 182-187 ◽  
Author(s):  
GARY C. BROWN ◽  
KENNETH MOFFAT ◽  
ALAN CRUESS ◽  
LARRY E. MAGARGAL ◽  
RICHARD E. GOLDBERG

Sign in / Sign up

Export Citation Format

Share Document